CD38 and acute myeloid leukemia: Recently, we reported that guaianolide sesquiterpene lactones could selectively inhibit AML stem and progenitor cells, and micheliolide (MCL, 1, Figure 1) was identified as the lead compound for reducing the proportion of AML stem cells (CD34+CD38−) in primary AML cells.